Objective: Recently, a seemingly novel innate immune cell subset bearing features of natural killer and B cells was identified in mice. So-called NKB cells appear as first responders to infections, but whether this cell population is truly novel or is in fact a subpopulation of B cells and exists in higher primates remains unclear. The objective of this study was to identify NKB cells in primates and study the impact of HIV/SIV infections.
which are predominantly present in the pleural and peritoneal cavities and also include marginal zone B cells, and other related B-cell phenotypes [1, 2] . Largely because of localization, ILB may be some of the first immune cells to come in contact with invading pathogens [2, 3] . ILB have highly cross-reactive B-cell receptors and/ or Toll like receptors that results in robust cytokine production and/or enhanced production of natural antibodies against virus and bacterial antigens [4] [5] [6] . ILB have also been shown to have immunoregulatory properties through the production of IL-10 [7] . Although characterization of ILB has proven to be challenging in humans, several studies looking at B cells in the blood have identified multiple memory CD5 þ IgM þ B-cell phenotypes that appear analogous to murine B1 cells [8] [9] [10] . Multiple studies have shown that phenotypic and functional B-cell abnormalities, including induction of a regulatory B-cell-like phenotype, are associated with HIV infection [11] [12] [13] [14] [15] . However, any role for ILB in HIV disease is largely unexplored.
Most recently, a novel subset of ILB has been identified in both humans and mice to share features of natural killer and B cells, and is an early source of multiple innate cytokines including IL-18 and IL-12 [16] . Natural killer-like B cells (NKB), like other ILB, also have semi-permanent expression of natural IgM, can activate natural killer and innate lymphoid cells following stimulation, and thus modulate a critical cascade of innate and adaptive immune responses eventually necessary to contain viral infections. However, Kerdiles et al. [17] questioned these findings and suggested that NKB in mice may not actually be a unique subset of B cell, but instead are just a subpopulation of conventional B cells. In rebuttal, Wang et al. [18] reported mRNA expression of genes encoding NK1.1 (klrb1c) and NKp46 (Ncr1) in murine NKB cells. In order to help clarify the existence of the proposed NKB population in higher primates, we investigated whether the putative phenotype exists in blood and tissues of humans and rhesus macaques, and if chronic HIV and simian immunodeficiency virus (SIV) infection may perturb this unique cell niche.
Methods
Macaque and human samples Peripheral blood mononuclear cells (PBMC) and tissue mononuclear cells isolated from spleen, mesenteric lymph nodes (MLN), and colon of naive rhesus macaques (n ¼ 18) were included in this study. PBMC and tissue mononuclear cells from spleen, colon, jejunum, MLN, oral lymph nodes (OLN), axillary lymph nodes (ALN), tonsils and jejunum from a chronically (140 days post challenge) SIVmac251-infected cohort (n ¼ 13) were also included. All animals were housed at Biomere (Worcester, MA, AAALC number 1152). All study samplings were reviewed and approved by the Biomere Institutional Animal Care and Use Committee. All animal housing and studies were carried out in accordance with recommendations detailed in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health with recommendations of the Weatherall report: 'The use of nonhuman primates in research.' Animals were fed standard monkey chow diet supplemented daily with fruit and vegetables and water ad libitum. Social enrichment was delivered and overseen by veterinary staff and overall animal health was monitored daily. Animals showing significant signs of weight loss, disease or distress were evaluated clinically and then provided dietary supplementation, analgesics, and/or therapeutics as necessary. Humane euthanasia was carried with an overdose of pentobarbital using standard protocols.
A total of 17 (PBMC and/or spleens) persons were analyzed in this study and the median ages were 46 years among naive individuals and 39 years among untreated viremic HIV-positive patients. Both the University of Alabama at Birmingham and Harvard University Institutional Review Board (IRB) reviewed and gave approval for the studies herein and written informed consent was obtained from each of the study participants. Frozen mononuclear cells from human naive spleen samples were provided by Massachusetts General Hospital and approved by the local IRB.
Flow cytometric staining of mononuclear cells
Mononuclear cells were characterized using surface and intracellular markers to discriminate B cells, natural killer cells and NKB cells. Using polychromatic flow cytometry cross-reactive antibodies against the following antigens were included: IgA (goat polyclonal; Rockland Immunochemical, Pottstown, Philadelphia, USA), IgG (G18-145; BD Biosciences, San Jose, California, USA), IgM (G20-127; BD Biosciences), CD20 (2H7; BD Biosciences), CD40 (5C3; BD Biosciences), HLA-DR (IMMU-157; Beckman Coulter, Indianapolis, Indiana, USA), NKG2A (Z199; Beckman Coulter), NKp46 (BAB281; Beckman Coulter), CD56 (HCD56; Biolegend, San Diego, California, USA), CD16 (3G8; BD Biosciences), CD127 (eBIORDR5; Life Technologies, Carlsbad, California, USA), and CD3 (SP34.2; BD Biosciences). Briefly, 1-2 Â 10 6 cells were first stained with Aqua dye for 30 min at room temperature for live/ dead separation. Cells were washed and stained for surface markers at 4 8C for 30 min and then fixed using a 1% formaldehyde solution. Intracellular staining for granzyme B (GB11; BD Biosciences) was performed using Fix/Perm reagents (Thermo Fisher Scientific, Waltham, Massachusetts, USA) according to the manufacturer's suggested protocol. Fixed samples were acquired on an LSRII (BD Biosciences) and analyzed using FlowJo software (version 9.9.4; Treestar, Ashland, Oregon, USA). Multiparametric analyses were performed using SPICE (v. 5.3; National Institute of Health, Bethesda, Maryland, USA) [19] . 
À cells as NKB cells in human samples. Although samples were negatively gated for CD127 to exclude innate lymphoid cells [20] , inclusion of CD127 expression on NKB did not alter the immunological profile.
RNA flow
Mononuclear cells were thawed and rested for 12 h in R10 media at 37 8C prior to surface and intracellular staining. RNA-flow hybridization was performed using the manufacturer's recommended protocol (PrimeFlow, Affymetrix, Santa Clara, California, USA) with the antibodies detailed in the flow cytometry section, and with rhesus macaque-specific KLRC1 and KLRC2 probesets. Rhesus-specific probesets were custom designed with the assistance of Affymetrix to target rhesus KLRC1 and KLRC2. Target probe sequences will be published elsewhere. Probesets were labeled with Alexa-488 (KLRC1) and Alexa-647 (KLRC2) fluorophores by Affymetrix. All KLRC1 and KLRC2 gates were determined per sample by comparing the samples stained with all antibodies and probesets with samples only stained with antibodies (no probeset control).
Virus quantification
Plasma HIV-1 RNA levels were determined using the Amplicor ultrasensitive HIV-1 monitor assay at UAB hospitals (version 1.5; Roche Diagnostics Systems, Indianapolis, Indiana, USA) [21] . SIV plasma RNA was quantified as described previously [22] .
Statistical analysis
Statistical differences between normal and HIV/SIV infected samples were analyzed by nonparametric MannÀWhitney U-test and were performed using GraphPad Prism v. 7 (La Jolla, California, USA). Statistical differences between pies were calculated by Permutation test as described [19] . Differences between mean ranks were considered significant at P < 0.05.
Results
Lymphocytes expressing phenotypic features of both natural killer and B cells are found in rhesus macaques On the basis of NKB cell phenotyping in mice described by Wang et al. [16] , we identified NKB as surface expression of other B cell and natural killer cellspecific markers (Fig. 1b) . NKB cells showed intermediate to low expression of HLA-DR and CD40, which are typically highly expressed on B cells but not on natural killer cells. NKB cells also expressed levels of the activating natural killer cell receptor NKp46 similar to rhesus macaque natural killer cells, but levels of the Fc receptor CD16 were notably intermediate compared to B cells (which were negative above background), but lower than the high CD16 expression found on natural killer cells in blood [23] . NKB cells also expressed unexpectedly high levels of intracellular granzyme B (Supplementary Fig 1, http:// links.lww.com/QAD/B277). Overall, this initial characterization suggested a cell type that uniquely overlapped phenotypically between B cells and natural killer cells.
To further confirm NKB cells as unique subset of B cells and to rule out nonspecific binding of natural killerspecific antibodies to B cells, we analyzed transcript expression of the natural killer genes NKG2A (KLRC1 mRNA) and NKG2C (KLRC2 mRNA) in spleen samples using RNA-flow. A minor subpopulation of B cells corresponding to NKB cells expressed KLRC1 and KLRC2 mRNA at similar density compared with natural killer cells (Fig. 2) . In addition, these cells co-expressed natural killer cell-specific surface proteins NKG2A/C, CD2, NKp30 and CD16 thus confirming the NKB cell population genuinely expressing natural killer cell markers.
Natural killer-like B cells are found systemically, but expand in the gastrointestinal tract during simian immunodeficiency virus infection Wang et al. [16] describe NKB cells as unique innate cells that prime other innate and adaptive lymphocytes. Following identification in rhesus macaques, we next characterized the NKB cell population in multiple tissues of naive and chronically SIV-infected macaques. The frequency of NKB cells varied significantly in normal tissues with a median of 0.012% in PBMC, a median of 0.047% in MLN, a median of 0.015% in colon, and a median of 0.191% in spleens (Fig. 3) . In SIV-infected macaques, NKB cells were significantly increased in PBMC and colon ( Fig. 3a and d) , but not in spleen or MLN (Fig. 3b and c) . Although not specifically addressed between groups in this study, NKB cells were also found in OLN, ALN, tonsil, and jejunum of SIV-infected animals ( Supplementary Fig 2, http://links.lww.com/ QAD/B277A) indicating their wide distribution. This particular cohort of SIV-infected macaques had a median viral load of 9.30 Â 10 5 copies/ml, plasma (range, 4.17 Â 10 4 À4.05 Â 10 7 copies), but there was no correlation between virus load and NKB frequencies. Further, the NKB cell phenotype was only partially modulated by SIV infection with significant upregulation of HLA-DR, CD16, CD40, and CD56 primarily restricted to spleen, but indicating a potential activation of these cells (Fig. 3E-H) . Natural killer-like B cells are found in human tissues, but not peripherally expanded by HIV infection To accommodate modest differences in phenotypic marker expression between human and macaque NK cells, we modified our gating strategy for human PBMC samples to identify NKB cells as CD3 (Fig. 4a) . Otherwise, the NKB cell subset showed remarkable similarity to the rhesus macaque subpopulation with overlapping expression profiles for B cell and natural killer cell-specific markers (Fig. 4b) , though more strikingly than in rhesus macaques (Fig. 1b) human NKB cells expressed CD40 and HLA-DR at levels comparable with B cells (Fig. 4b) . The range of NKB cell frequencies in human PBMC and spleen were similar to what was observed in rhesus macaques (medians 0.012 and 0.011% of lymphocytes, respectively; Fig. 4c, Supplementary Fig 2, http:// links.lww.com/QAD/B277B). However, no significant differences in NKB frequencies were found between normal and HIV-infected/ART naive individuals (median viral load of 4.89 Â 10 4 copies/ml, plasma; range, 2.30 Â 10 4 À3.41 Â 10 5 copies/ml, plasma). The phenotypic profiles of human NKB cells were generally retained, but similar to what was observed in some rhesus macaque tissues there was an upregulation of CD56 (Fig. 4d) .
Surface immunoglobulin expression on natural killer-like B cells
As a more robust indicator to determine NKB cell similarities to true B cells, we next investigated the breadth of surface Ig expression in both normal and SIVinfected macaques and naive and HIV-1-infected humans. Notably, the proportion of NKB expressing any type of Ig was highly variable and appeared to be more stable in humans (3À87% in rhesus macaques, 59À99% in humans). However, the diversity of expression on positive cells revealed unique patterns (Fig. 5) . Surface IgA and IgM were almost universally expressed in PBMC, spleen, and MLN of both species (up to 99% in humans), and these findings are very similar to the initial description of stable IgM on murine NKB cells and other ILB [16, 24] . IgG was expressed at much lower levels in normal individuals, but increased up to 10-fold in spleen and MLN of SIV-infected macaques. In contrast, IgG upregulation was not observed in PBMC of HIVinfected persons.
Discussion
Multiple lines of evidence suggest HIV and SIV infection may dysregulate B cell and natural killer cell functions [11] [12] [13] [14] 23, [25] [26] [27] . Conversely, mobilization of anti-HIV/SIV antibodies is considered at the forefront of effective vaccination, alternative antivirals, and curative therapeutics against these diseases. However, very little is known about ILB populations that stably express Ig molecules and rapidly secrete innate cytokines, and how they may play into the dynamics of HIV transmission, disease progression, and treatment and preventive strategies. Herein, we present several seminal findings: identification of a cellular phenotype in multiple macaque and human tissues bearing verifiable features of both B cells and natural killer cells; expansion of putative NKB cells in the mucosae of chronically SIVinfected macaques; and a lentivirus-driven shift in immunoglobulin expression on NKB cells. Whether NKB cells truly represent a stable independent cell has been heavily debated. Although multiple future studies will be required to scrutinize this cell type, we do present several findings that support its existence. Phenotypically, CD3 À CD20 þ cells expressing natural killer cell-specific markers were found in multiple tissues of two different primate species. These findings could possibly be explained by membrane exchange or nonspecific antibody binding. However, our demonstration of NKG2A/C transcripts in these cells makes that extremely unlikely. One of the most striking findings in this study was an overall expansion of NKB in circulation and in the colon during chronic SIV infection. Scientifically this may not be surprising, given the high level of virus replication and cell death in the gastrointestinal tract, coupled with the putative role of NKB cells as rapid responders to infectious pathogens. The expansion did not however, correlate with virus loads, and no expansion was observed in the circulation of HIV-1-infected patients. This could be attributed, at least in part, to species differences, the fact that human colorectal samples could not be analyzed in this cohort where the expansion was more striking, or that NKB are most sensitive to sites of very high inflammation. It is also likely that the large differences in viral loads between SIV-infected macaques and HIVinfected humans in this study (>1 log) contributed to this distinction. SIV set points are traditionally much greater than in HIV-infected humans [28] and this study was not powered to address these types of differences. Another unique finding was the virus-induced alteration in Ig expression. It is tempting to speculate that the stable innate IgM and IgA expression shifting to IgG may reflect NKB cell plasticity and a novel switch from innate to adaptive immunity. Interestingly though IgG upregulation was significant in macaques but not in humans. Again as the increase was most prominent in tissues (which were not available from HIV-infected persons), this may not fully reflect the state of the cells in infection, but could also be a species or virus difference.
NKB cells induced by SIV infection
We acknowledge that the findings and theoretical niche of NKB cells remain controversial, but we present our findings, as they are to help further the resolution of this unexpected finding. Our data suggest that the NKB cell phenotype, regardless of unknown ontogeny is likely a real one. However, much as was previously suggested [17] , we speculate NKB cells are a subpopulation of B cells that unexpectedly shares some properties overlapping with natural killer cells, the functional reasons for which remain unclear. Strikingly these cells are also significantly perturbed during lentivirus infection. Future studies will be needed to address the mechanism behind these phenomena in tissues of humans and macaques in both early and late infections. 
